Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or Without Allodynia: a Regional Multicenter Prospective Cohort

Status: Recruiting
Location: See all (10) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

Prospective multicenter cohort to determine patient profiles (associated factors, including allodynia) with a better response to pain desensitization by capsaicin delivered in the form of a high concentration patch (8%), in a population of patients with peripheral neuropathic pain and followed up in a pain consultation in the Auvergne Rhône Alpes region.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patient over 18 years of age on the day of inclusion

• Patient who has been informed and has not expressed opposition to participating in the study,

• Patient with peripheral neuropathic pain (whatever the etiology), defined by :

‣ Neuropathic Pain 4 score (DN4 score) ≥ 4/10

⁃ AND pain according to the numerical scale (EN) \> 4/10,

⁃ AND stable analgesic treatment for at least 1 month,

⁃ AND with or without mechanical allodynia according to the Quantitative Sensory Testing (QST) : Brush test (dynamic), Von Frey test (static)

⁃ AND with or without thermal allodynia to hot or cold as determined by a ROLLTEMP-II® (Rolltemp is a device designed for quick screening of temperature sensibility over large body areas).

• Patient responding to an indication of desensitization to high concentration capsaicin concentration and not presenting any contra-indication.

• Patient naïve of high concentration of Capsaicin on the concerned zone

• Patient understanding French

Locations
Other Locations
France
Centre Hospitalier Annecy Genevois
RECRUITING
Annecy
Hospices Civils de Lyon, Hôpital Pierre Wertheimer
NOT_YET_RECRUITING
Bron
Centre Hospitalier Métropole Savoie
RECRUITING
Chambéry
Centre Hospitalier Universitaire de Clermont-Ferrand
NOT_YET_RECRUITING
Clermont-ferrand
Centre Hospitalier Universitaire Grenoble-Alpes
RECRUITING
Grenoble
Centre Léon Bérard
RECRUITING
Lyon
Hospices Civils de Lyon, Hôpital de la Croix Rousse
NOT_YET_RECRUITING
Lyon
Centre Hospitalier Universitaire de Saint-Etienne
NOT_YET_RECRUITING
Saint-etienne
Clinique Mutualiste Chirurgicale de Saint Etienne
RECRUITING
Saint-etienne
Médipôle Lyon Villeurbanne
NOT_YET_RECRUITING
Villeurbanne
Contact Information
Primary
Marion GHIDI
drci.promotion@ch-annecygenevois.fr
+33450637031
Time Frame
Start Date: 2023-12-14
Estimated Completion Date: 2026-06-15
Participants
Target number of participants: 400
Treatments
Patients with peripheral neuropathic pain and having an indication of capsaicin patches
All patients will receive as part of routine care:~* Three consecutive patches of 8% capsaicin in localized application for 30 to 60 minutes once every 3 months : at M0 (study inclusion), M3 and M6, or until pain scale \< 4/10 (between 0 and 10),~* Pain assessment every 1.5 months (+/-7 days), to evaluate clinical response,~* 8% capsaicin patches if the pain assessment rises again to pain scale \> 4/10, after an initial response to treatment
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Annecy Genevois

This content was sourced from clinicaltrials.gov

Similar Clinical Trials